BioNTech SE (22UA.F)

EUR 107.0

(-2.28%)

Gross Profit Summary of BioNTech SE

BioNTech SE's latest annual gross profit in 2023 was 3.21 Billion EUR , down -74.81% from previous year.
BioNTech SE's latest quarterly gross profit in 2024 Q2 was 69.24 Million EUR , down -46.43% from previous quarter.
BioNTech SE reported a annual gross profit of 12.77 Billion EUR in annual gross profit 2022, down -15.46% from previous year.
BioNTech SE reported a annual gross profit of 15.11 Billion EUR in annual gross profit 2021, up 6907.87% from previous year.
BioNTech SE reported a quarterly gross profit of 129.25 Million EUR for 2024 Q1, down -90.06% from previous quarter.
BioNTech SE reported a quarterly gross profit of -368.6 Million EUR for 2023 Q2, down -143.52% from previous quarter.

Annual Gross Profit Chart of BioNTech SE (2023 - 2017)

Historical Annual Gross Profit of BioNTech SE (2023 - 2017)

Year	Gross Profit	Gross Profit Growth
2023	3.21 Billion EUR	-74.81%
2022	12.77 Billion EUR	-15.46%
2021	15.11 Billion EUR	6907.87%
2020	-222.03 Million EUR	-64.18%
2019	-135.23 Million EUR	-363.86%
2018	-29.15 Million EUR	12.23%
2017	-33.21 Million EUR	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q2	69.24 Million EUR	-46.43%
2024 Q1	129.25 Million EUR	-90.06%
2023 Q2	-368.6 Million EUR	-143.52%
2023 Q4	1.29 Billion EUR	451.74%
2023 FY	3.21 Billion EUR	-74.81%
2023 Q3	235.6 Million EUR	163.92%
2023 Q1	847 Million EUR	-76.37%
2022 Q4	3.58 Billion EUR	51.48%
2022 Q2	2.03 Billion EUR	-57.61%
2022 Q1	4.79 Billion EUR	2.5%
2022 FY	12.77 Billion EUR	-15.46%
2022 Q3	2.36 Billion EUR	16.45%
2021 Q3	4.61 Billion EUR	9.28%
2021 Q1	1.81 Billion EUR	3726.44%
2021 Q2	4.22 Billion EUR	132.67%
2021 FY	15.11 Billion EUR	6907.87%
2021 Q4	4.67 Billion EUR	1.35%
2020 FY	-222.03 Million EUR	-64.18%
2020 Q4	47.44 Million EUR	128.39%
2020 Q3	-167.08 Million EUR	-182.77%
2020 Q2	-59.08 Million EUR	-36.46%
2020 Q1	-43.3 Million EUR	-3.41%
2019 Q1	-34.29 Million EUR	-556.74%
2019 Q3	-25.96 Million EUR	21.57%
2019 Q4	-41.87 Million EUR	-61.28%
2019 FY	-135.23 Million EUR	-363.86%
2019 Q2	-33.1 Million EUR	3.46%
2018 Q2	18.48 Million EUR	0.0%
2018 Q1	18.48 Million EUR	0.0%
2018 Q3	-15.17 Million EUR	-182.1%
2018 Q4	7.5 Million EUR	149.49%
2018 FY	-29.15 Million EUR	12.23%
2017 FY	-33.21 Million EUR	0.0%

Peer Gross Profit Comparison of BioNTech SE

Name	Gross Profit	Gross Profit Difference
CureVac N.V.	-70.6 Million EUR	4659.257%
Biotest Aktiengesellschaft	271.9 Million EUR	-1083.965%
Biotest Aktiengesellschaft	271.9 Million EUR	-1083.965%
BRAIN Biotech AG	30.12 Million EUR	-10587.205%
Formycon AG	23.3 Million EUR	-13713.345%
Heidelberg Pharma AG	6.6 Million EUR	-48630.837%
Medigene AG	4.39 Million EUR	-73213.596%